118 related articles for article (PubMed ID: 10809176)
1. Adenosine and its receptor agonists regulate nitric oxide production and RAW 264.7 macrophages via both receptor binding and its downstream metabolites-inosine.
Min HW; Moochhala S; Eng KH
Life Sci; 2000 Mar; 66(19):1781-93. PubMed ID: 10809176
[TBL] [Abstract][Full Text] [Related]
2. Adenosine and its receptor agonists potentiate nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages.
Hon WM; Moochhala S; Khoo HE
Life Sci; 1997; 60(16):1327-35. PubMed ID: 9096253
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.
Haskó G; Szabó C; Németh ZH; Kvetan V; Pastores SM; Vizi ES
J Immunol; 1996 Nov; 157(10):4634-40. PubMed ID: 8906843
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells.
Dubey RK; Gillespie DG; Jackson EK
Hypertension; 1998 Jan; 31(1 Pt 2):296-302. PubMed ID: 9453319
[TBL] [Abstract][Full Text] [Related]
5. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors.
Sperlágh B; Haskó G; Németh Z; Vizi ES
Neurochem Int; 1998 Sep; 33(3):209-15. PubMed ID: 9759915
[TBL] [Abstract][Full Text] [Related]
6. Mechanism that regulates nitric oxide production by lipopolysaccharide-stimulated rat Kupffer cells.
Ikeda K; Kubo S; Hirohashi K; Kinoshita H; Kaneda K; Kawada N; Sato EF; Inoue M
Physiol Chem Phys Med NMR; 1996; 28(4):239-53. PubMed ID: 9153798
[TBL] [Abstract][Full Text] [Related]
7. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
[TBL] [Abstract][Full Text] [Related]
8. Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia.
Hon WM; Khoo HE; Ngoi SS; Moochhala S
Biochem Pharmacol; 1995 Jun; 50(1):45-7. PubMed ID: 7541626
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
Kang JS; Jeon YJ; Kim HM; Han SH; Yang KH
J Pharmacol Exp Ther; 2002 Jul; 302(1):138-44. PubMed ID: 12065710
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to lipopolysaccharide is related to the nitric oxide pathway.
Almeida MC; Trevisan FN; Barros RC; Carnio EC; Branco LG
Neuroreport; 1999 Sep; 10(14):3061-5. PubMed ID: 10549823
[TBL] [Abstract][Full Text] [Related]
11. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
[TBL] [Abstract][Full Text] [Related]
12. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G
Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512
[TBL] [Abstract][Full Text] [Related]
13. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
14. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
[TBL] [Abstract][Full Text] [Related]
15. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ
J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236
[TBL] [Abstract][Full Text] [Related]
16. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774.
Blix IJ; Helgeland K
Eur J Oral Sci; 1998 Feb; 106(1):576-81. PubMed ID: 9527358
[TBL] [Abstract][Full Text] [Related]
17. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide.
Chen YC; Shen SC; Chen LG; Lee TJ; Yang LL
Biochem Pharmacol; 2001 Jun; 61(11):1417-27. PubMed ID: 11331078
[TBL] [Abstract][Full Text] [Related]
18. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
Correia-de-Sá P; Ribeiro JA
Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
[TBL] [Abstract][Full Text] [Related]
19. Yomogin, an inhibitor of nitric oxide production in LPS-activated macrophages.
Ryu JH; Lee HJ; Jeong YS; Ryu SY; Han YN
Arch Pharm Res; 1998 Aug; 21(4):481-4. PubMed ID: 9875481
[TBL] [Abstract][Full Text] [Related]
20. 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells.
Kim YH; Woo KJ; Lim JH; Kim S; Lee TJ; Jung EM; Lee JM; Park JW; Kwon TK
Biochem Biophys Res Commun; 2005 Apr; 329(2):591-7. PubMed ID: 15737626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
